Observational Study
Copyright ©The Author(s) 2021.
World J Hepatol. Apr 27, 2021; 13(4): 504-514
Published online Apr 27, 2021. doi: 10.4254/wjh.v13.i4.504
Table 2 Bivariate analysis of sociodemographic and clinical characteristics according to hepatitis B virus and hepatitis C virus markers in chronic kidney disease individuals
VariableAdjustmentHBsAg
Anti-HBc
Anti-HCV
DBS
Serum
DBS
Serum
DBS
Serum
AcupunctureOR crude (95%CI)---4.0 (1.5-10.6)--
OR adjusted (95%CI)---5.1 (1.8-14.5)--
Shared nail cutters/razor /toothbrushOR crude (95%CI)--2.6 (1.4-4.6)1.9 (1.1-3.2)--
OR adjusted (95%CI)--2.7 (1.5-4.8)2.6 (1.5-4.7)--
History of transplantOR crude (95%CI)--2.9 (1.3-6.4)-5.8 (2.5-13.6)5.8 (2.5-13.6)
OR adjusted (95%CI)--2.7 (1.2-6.1)-2.8 (1.1-7.4)2.8 (1.1-7.7)
Infrequent condom useOR crude (95%CI)5.6 (1.6-16.4)4.4 (1.4-14.5)----
OR adjusted (95%CI)5.6 (1.6-16.4)4.4 (1.4-14.5)----
Hemodialysis time (mo)OR crude (95%CI)---1.01 (1.01-1.01)1.01 (1.01-1.02)1.01 (1.01-1.01)
OR adjusted (95%CI)---1.01 (1.01-1.01)1.01 (1.01-1.02)1.01 (1.01-1.02)
Hemodialysis 4 times per week or moreOR crude (95%CI)-----2.8 (1.1-6.9)
OR adjusted (95%CI)-----2.7 (1.1-7.4)